Follow
Shubhankar Ambike
Title
Cited by
Cited by
Year
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread
S Ambike, CC Cheng, M Feuerherd, S Velkov, D Baldassi, SQ Afridi, ...
Nucleic Acids Research 50 (1), 333-349, 2022
492022
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes
D Baldassi, S Ambike, M Feuerherd, CC Cheng, DJ Peeler, DP Feldmann, ...
Journal of Controlled Release 345, 661-674, 2022
272022
Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identifies ORF1 as promising target
S Ambike, C Cheng, S Afridi, M Feuerherd, P Hagen, V Grass, O Merkel, ...
52020
Partial pol Sequences from Drug Naive HIV-2 Infected Individuals from Maharashtra, India
SS Ambike, MR Thakar, AA Patil, RR Gangakhedkar, SN Kurle
AIDS Research and Human Retroviruses 35 (5), 505-508, 2019
42019
Unravelling the role of hepatocytes in hepatitis B virus specific immunotolerance
M Zehentmeier, S Ambike, U Protzer, T Michler
Zeitschrift für Gastroenterologie 60 (01), P 5.33, 2022
12022
RECOMBINANT MOSAIC HBV CAPSID PARTICLES FOSTER ADAPTIVE IMMUNITY AGAINST THE MOST PREVALENT HBV GENOTYPES BY THERAPEUTIC VACCINATION
S Ambike, J Sacherl, A Seidler, A Geerlof, A Kosinska, S Schreiber, ...
HEPATOLOGY 78, S586-S586, 2023
2023
SARS-CoV-2 productively infects human hepatocytes and induces cell death
CC Cheng, C Ko, S Ambike, J Sacherl, S Velkov, BH Liao, R Bester, ...
2023
ORF1 REGION of SARS-C V-2 GENOMIC RNA AS A PROMISING TARGET for siRNA-BASED THERAPY
S Ambike, CC Cheng, M Feuerherd, D Baldassi, S Velkov, G Burgstaller, ...
Topics in Antiviral Medicine, 67-67, 2022
2022
Systematic analysis of RNAi-accessible SARS-CoV-2 replication steps identifies ORF1 as promising target (preprint)
S Ambike, CC Cheng, S Afridi, M Feuerherd, P Hagen, V Grass, O Merkel, ...
2020
The system can't perform the operation now. Try again later.
Articles 1–9